Mesenteric vasodilation mediated by endothelial anandamide receptors

被引:218
作者
Wagner, JA [1 ]
Varga, K [1 ]
Járai, Z [1 ]
Kunos, G [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
vasodilation; cannabinoids; anandamide; endotoxin;
D O I
10.1161/01.HYP.33.1.429
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Cannabinoids, including the endogenous ligand anandamide (arachidonyl ethanolamide), elicit pronounced hypotension in rats via activation of peripherally located CB1 cannabinoid receptors, which have been also implicated in endotoxin (lipopolysaccharide [LPS])-induced hypotension. The present study was designed to test the role of vascular CB1 receptors in cannabinoid- and endotoxin-induced mesenteric vasodilation, In the isolated, buffer-perfused rat mesenteric arterial bed precontracted with phenylephrine, anandamide induced long-lasting (up to 60 minutes) dose-dependent vasodilation (ED50: 79+/-3 nmol; maximal relaxation: 77+/-2%), inhibited by 0.5 to 5.0 mu mol/L of the selective CB1 receptor antagonist SR141716A. Low doses of the calcium ionophore ionomycin also caused mesenteric vasodilation inhibited by SR141716A. The metabolically stable analogue R-methanandamide elicited mesenteric vasodilation (ED50: 286+/-29 nmol), whereas the potent synthetic CB1 receptor agonists WIN 55212-2 and HU-210 caused no change in vascular tone or only a minor dilator effect not affected by SR141716A, respectively. The endogenous ligand 2-arachidonyl glycerol caused no change in vascular tone, whereas Delta(9)-tetrahydrocannabinol and arachidonic acid caused mesenteric vasoconstriction. After endothelial denudation, the dilator response to anandamide was slightly reduced and was no longer inhibited by SR141716A, In preparations from LPS-pretreated rats, SR141716A alone caused a significant and prolonged increase in perfusion pressure, whereas it had no such effect in control preparations perfused in vitro with or without LPS or after endothelial denudation in preparations from rats pretreated with LPS. We conclude that anandamide-induced mesenteric vasodilation is mediated by an endothelially located SR141716A-sensitive "anandamide receptor" distinct from CB1 cannabinoid receptors and that activation of such receptors by an endocannabinoid, possibly anandamide, contributes to LPS-induced mesenteric vasodilation in vivo.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 38 条
  • [21] Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
    Plane, F
    Holland, M
    Waldron, GJ
    Garland, CJ
    Boyle, JP
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) : 1509 - 1511
  • [22] N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
    Pratt, PF
    Hillard, CJ
    Edgemond, WS
    Campbell, WB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01): : H375 - H381
  • [23] A CRITICAL ROLE FOR MONOCYTES AND CD14 IN ENDOTOXIN-INDUCED ENDOTHELIAL-CELL ACTIVATION
    PUGIN, J
    ULEVITCH, RJ
    TOBIAS, PS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2193 - 2200
  • [24] An endogenous cannabinoid as an endothelium-derived vasorelaxant
    Randall, MD
    Alexander, SPH
    Bennett, T
    Boyd, EA
    Fry, JR
    Gardiner, SM
    Kemp, PA
    McCulloch, AI
    Kendall, DA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (01) : 114 - 120
  • [25] SR141716A, A POTENT AND SELECTIVE ANTAGONIST OF THE BRAIN CANNABINOID RECEPTOR
    RINALDICARMONA, M
    BARTH, F
    HEAULME, M
    SHIRE, D
    CALANDRA, B
    CONGY, C
    MARTINEZ, S
    MARUANI, J
    NELIAT, G
    CAPUT, D
    FERRARA, P
    SOUBRIE, P
    BRELIERE, JC
    LEFUR, G
    [J]. FEBS LETTERS, 1994, 350 (2-3): : 240 - 244
  • [26] Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system
    Schatz, AR
    Lee, M
    Condie, RB
    Pulaski, JT
    Kaminski, NE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 142 (02) : 278 - 287
  • [27] AN AMINO-TERMINAL VARIANT OF THE CENTRAL CANNABINOID RECEPTOR RESULTING FROM ALTERNATIVE SPLICING
    SHIRE, D
    CARILLON, C
    KAGHAD, M
    CALANDRA, B
    RINALDICARMONA, M
    LEFUR, G
    CAPUT, D
    FERRARA, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) : 3726 - 3731
  • [28] Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989
  • [29] A second endogenous cannabinoid that modulates long-term potentiation
    Stella, N
    Schweitzer, P
    Piomelli, D
    [J]. NATURE, 1997, 388 (6644) : 773 - 778
  • [30] 2-ARACHIDONOYLGYLCEROL - A POSSIBLE ENDOGENOUS CANNABINOID RECEPTOR-LIGAND IN BRAIN
    SUGIURA, T
    KONDO, S
    SUKAGAWA, A
    NAKANE, S
    SHINODA, A
    ITOH, K
    YAMASHITA, A
    WAKU, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (01) : 89 - 97